Study of the Efficacy of 532nm Laser and 1064 nm Laser in the Treatment of Cutaneous Lupus Erythematous Versus Topical Corticosteroids Alone



Status:Recruiting
Conditions:Lupus
Therapuetic Areas:Immunology / Infectious Diseases
Healthy:No
Age Range:18 - Any
Updated:8/29/2018
Start Date:July 13, 2018
End Date:December 31, 2018
Contact:David Weinstein, MD
Email:david.weinstein@ucf.edu
Phone:407-266-4900

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

A Comparative Study of the Efficacy of 532nm Laser and 1064 nm Laser in the Treatment of Cutaneous Lupus Erythematous Versus Topical Corticosteroids Alone

This study aims to compare the efficacy of 532nm Potassium Titanyl Phosphate (KTP) laser and
1064 nm Neodymium-doped Yttrium Aluminum Garnet (Nd:YAG) laser as adjuncts to topical
corticosteroids in the treatment of cutaneous lupus erythematosus versus topical
corticosteroids alone.


Inclusion Criteria:

- Male or female adult 18 years of age or older

- Ability to rate level of pain

- Ability to rate visual satisfaction

- At least 2 active lesions of CLE

Exclusion Criteria:

- New or change in systemic medication for cutaneous lupus in past 6 months

- Allergy to triamcinolone or betamethasone dipropionate cream

- Pregnancy

- Currently a prisoner

- Unable to read and speak English since consent will only be available in English
We found this trial at
1
site
UCF Health Lake Nona Office
9975 Tavistock Lakes Boulevard
Orlando, Florida 32827
Principal Investigator: David Weinstein, MD
Phone: 407-266-4900
?
mi
from
Orlando, FL
Click here to add this to my saved trials